Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 65 resultados

ERDERA: EUROPEAN RARE DISEASES RESEARCH ALLIANCE REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-HLTH-2023-DISEASE-07 The European Rare Diseases Research Alliance (ERDERA) aims to improve the health and well-being of the 30 million people living with a rare...
2024-08-20 - 2031-08-31 | Financiado

InSilicoHealth: InSilicoHealth Training the virtual twin professionals to support healthy ageing InSilicoHealth aims to train doctoral candidates in the field of virtual human twin technology, with a specific focus on addressing challeng...
2024-07-05 - 2029-12-31 | Financiado

TETRIS: Risk assessment Tools for severe side Effects after breasT Radiotherapy radiation safety through b... Radiation protection and safety measures are essential to ensure adequate quality & safety in radiotherapy (RT). Side effects are systematic...
2024-06-28 - 2027-09-30 | Financiado

AD-RIDDLE: REAL-WORLD IMPLEMENTATION, DEPLOYMENT AND VALIDATION OF EARLY DETECTION TOOLS AND LIFESTYLE ENHANCEM... REGION STOCKHOLM tramitó un HORIZON EUROPE: HORIZON-JU-IHI-2022-03-single-stage Alzheimer's disease (AD), the main cause of dementia, is one of the major global health challenges of our time. This disabling disorder affe...
2024-01-01 - 2028-12-31 | Financiado

ENDEAVOR: Endoscopic brush cytology and single cell clinal dynamics of early easophageal adenocarcinoma for de... REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-MISS-2023-CANCER-01 In many European countries the recent rise in incidence of esophageal adenocarcinoma (EAC) is without precedent. EAC is notorious for its h...
2023-12-11 - 2028-12-31 | Financiado

GUIDE.MRD: GUIding multi-moDal thErapies against MRD by liquid biopsies - GUIDE.MRD REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Advancing personalized approaches in cancer therapy, aiding identification and adaptation of multi-modal treatment strategies for improved o...
2023-05-17 - 2028-04-30 | Financiado

PragmaTIL: Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in sele... REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-MISS-2022-CANCER-01 The PragmaTIL trial aims to optimize treatment of cancer patients with Tumour-Infiltrating Lymphocytes Adoptive Cell Therapy (TIL-ACT) and s...
2023-04-28 - 2028-03-31 | Financiado

PROMINENT: PRECISION MEDICINE PLATFORM IN NEURODEGENERATIVE DISEASE REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-JU-IHI-2022-01-single-stage Neurodegenerative diseases are one of the most important contributors to morbidity and mortality in the elderly. In Europe, over 14 million...
2023-04-25 - 2028-04-30 | Financiado

STRATA-FIT: Stratification of Rheumatoid Arthritis: CompuTational models to personalise mAnagement strategies fo... REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-HLTH-2022-TOOL-12-two-stage Difficult-to-treat rheumatoid arthritis (D2T RA) is an area of huge unmet medical need with major socio-economic consequences for patients a...
2023-04-07 - 2029-04-30 | Financiado

PANCAID: PANcreatic CAncer Initial Detection via liquid biopsy REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 Pancreatic cancer (PDAC) is usually detected at late stages and most patients die within one year after diagnosis. In PANCAID we will theref...
2022-12-02 - 2027-12-31 | Financiado

PREVENTABLE: CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-HLTH-2022-CARE-08 Rare tumour risk syndromes (RTRS) are rare diseases, affecting 5 per 10.000 people or less and caused by heritable genetic variants. In RTRS...
2022-12-02 - 2025-12-31 | Financiado

MELCAYA: Novel health care strategies for melanoma in children adolescents and young adults REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-MISS-2021-CANCER-02 "In childhood, adolescence and young adults (CAYA), melanoma is under-studied and non-existing tailored clinical guidelines and standardized...
2022-12-01 - 2026-11-30 | Financiado

R4C: Regions4Climate Increasingly frequent extreme weather conditions due to climate change concomitant with unsustainable historical resource use and management...
2022-11-23 - 2027-12-31 | Financiado

fitsCAN: Blood flow induced thrombosis and stenosis due to cannulation – an interdisciplinary study REGION STOCKHOLM participó en un HORIZON EUROPE: ERC-2021-COG In extracorporeal organ support (ECOS), one or more organ functions fail and are replaced by an artificial device. Kidney failure requires h...
2022-06-03 - 2027-08-31 | Financiado

DataTools4Heart: A European Health Data Toolbox for Enhancing Cardiology Data Interoperability Reusability and Priva... REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 Cardiovascular disease (CVD) remains the main cause of mortality worldwide, accounting for about a third of annual deaths. Re-use of both st...
2022-06-03 - 2026-09-30 | Financiado

D-SOLVE: Understanding the individual host response against Hepatitis D Virus to develop a personalized appro... REGION STOCKHOLM participó en un HORIZON EUROPE: HORIZON-HLTH-2021-DISEASE-04 Hepatitis D is by far the most severe form of chronic viral hepatitis frequently leading to liver failure, hepatocellular carcinoma and deat...
2022-05-25 - 2026-09-30 | Financiado

VACCELERATE: VACCELERATE European Corona Vaccine Trial Accelerator Platform REGION STOCKHOLM participó en un H2020: The ongoing COVID-19 pandemic creates an unprecedented burden worldwide. Vaccine-induced immunity is the only promising solution. There is c...
2021-02-17 - 2024-01-27 | Financiado

EHRA - PATHS: Addressing multimorbidity in elderly atrial fibrillation patients through interdisciplinary tailore... REGION STOCKHOLM participó en un H2020: H2020-SC1-BHC-2018-2020 Optimization of atrial fibrillation (AF) disease management is highly needed. The AF prevalence is 7.8% above the age of 65 years and it wil...
2021-01-22 - 2026-03-31 | Financiado

CARDIOCARE: AN INTERDISCIPLINARY APPROACH FOR THE MANAGEMENT OF THE ELDERLY MULTIMORBID PATIENT WITH BREAST CANC... REGION STOCKHOLM participó en un H2020: H2020-SC1-BHC-2018-2020 More than 50% of the newly diagnosed breast cancer patients are elderly and particularly susceptible to cardiotoxicity of cancer treatment d...
2021-01-22 - 2025-06-30 | Financiado

REBECCA: REsearch on BrEast Cancer induced chronic conditions supported by Causal Analysis of multi source da... REGION STOCKHOLM participó en un H2020: H2020-SC1-BHC-2018-2020 The REBECCA proposal aspires to tap into the potential of Real-world Data (RWD) for supporting groundbreaking clinical research on complex c...
2021-01-18 - 2025-09-30 | Financiado